Xinzhong Chang

Statistics

Publications

Citations

154

H-Index

Active since

2014

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Tianjin Medical University

Xinzhong Chang is an author at Tianjin Medical University Cancer Institute and Hospital specializing in oncology, cancer cell signaling, and molecular oncology.

ORCID

Publications per year

2014–2021

Publications

Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cells

Lingling Wang, Jiashen Sun, Yueyuan Yin et al. · Cell Death and Disease · 2021 · 42 citations · Full text

Medicine, Molecular Biology, Oncology +17

SPIB promotes anoikis resistance via elevated autolysosomal process in lung cancer cells

Hua Zhang, Guobin Wang, Ruimin Zhou et al. · FEBS Journal · 2020 · 38 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-<i>κ</i>B Signaling Pathway in Human Breast Cancer Cells

Xiao-Hu Sun, Xinzhong Chang, Yunhua Wang et al. · BioMed Research International · 2019 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +13

Spleen tyrosine kinase <scp>SYK</scp>(L) interacts with <scp>YY</scp>1 and coordinately suppresses <i><scp>SNAI</scp>2</i> transcription in lung cancer cells

Dan Gao, Lingling Wang, Hua Zhang et al. · FEBS Journal · 2018 · 22 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

Association of PKCζ Expression with Clinicopathological Characteristics of Breast Cancer

Jian Yin, Zhi‐Pei Liu, Haixin Li et al. · PLoS ONE · 2014 · 15 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–5 of 5